Área Oncología

Breast cancer biology research group

Ana Lluch Hernández

Dr. Lluch graduated from the Faculty of Medicine and Odontology at the University of Valencia in 1978. In 1985 she obtained a doctorate from the same university, also receiving the Outstanding Doctoral Thesis Special Prize. She has taken advantage of several residences at relevant centers abroad, such as the Tumors Institute in Milan in the Experimental Biology Laboratory or at the Hospital MD Anderson Cancer Centre in Houston as part of the breast cancer service.

She is now a permanent Senior Professor of Medicine in the Faculty of Medicine at the University of Valencia and is the head of the Hematology and Medical Oncology Department at the Hospital Clínico Universitario in Valencia.

Her work as the Principal Investigator of the Breast Cancer Biology Research Group at the INCLIVA foundation especially stands out. In particular, it is worth mentioning her contribution to identifying and evaluating tumor markers that can serve as prognostic and predictive factors of therapeutic responses in breast cancer.

She is a member of the Spanish Breast Cancer Research Group (GEICAM; Grupo Español de Investigación en Cáncer de Mama) and is involved in the development of several clinical trials at the national and international level as part of the SOLTI group. She is also an evaluator and Editorial Committee member of prestigious journals, and a member of the European Society for Medical Oncology and the American Society of Clinical Oncology. Among several roles, she has been a member of the Steering Committee of the Spanish Society of Medical Oncology (SEOM; Sociedad Española de Oncología Médica), the Deputy Chairwoman of the Spanish Society of Senology and Mammary Pathology, and member of the Breast Cancer Studies Foundation (Fundación de Estudios Mastológicos).

She is the editor-author of more than 15 books and a collaborating-author on several medical oncology books. She has published more than 235 scientific manuscripts and has managed more than 20 doctoral thesis students in the Faculty of Medicine at the University of Valencia.

The many awards she has received include the following: the Working Woman Award, the Isabel de Villena Award and the Isabel Ferrer Award, the Health and Society Award, the Health worker 2000 Award, the Scientific Merit Distinction awarded by the Generalitat Valenciana (Valencian regional government) and more recently, the Medal of the University of Valencia.

Since 1 April 2014 she has been a permanent member of the Valencian Autonomous Community’s Royal Academy of Medicine and Science (Reial Acadèmia de Medicina i Ciències de la Comunitat Valenciana).


Her work focuses on the diagnosis and the treatment of breast cancer:
•   Deepening the understanding of the genetic and genomic basis of breast cancer.
•   Identifying genes involved in tumor processes and application and development of new genomic screening technologies, contributing to faster and more effective diagnosis and a better understanding of cancer.
•   Search for new biological strategies which allow the individualization of treatments.